Perspective of mesenchymal transformation in glioblastoma
Despite aggressive multimodal treatment, glioblastoma (GBM), a grade IV primary brain
tumor, still portends a poor prognosis with a median overall survival of 12–16 months. The …
tumor, still portends a poor prognosis with a median overall survival of 12–16 months. The …
Laser interstitial thermotherapy (LITT) for the treatment of tumors of the brain and spine: a brief review
Abstract Introduction Laser Interstitial Thermotherapy (LITT; also known as Stereotactic
Laser Ablation or SLA), is a minimally invasive treatment modality that has recently gained …
Laser Ablation or SLA), is a minimally invasive treatment modality that has recently gained …
Current multidisciplinary management of brain metastases
Brain metastasis (BM), the most common adult brain tumor, develops in 20% to 40% of
patients with late‐stage cancer and traditionally are associated with a poor prognosis. The …
patients with late‐stage cancer and traditionally are associated with a poor prognosis. The …
Hyperthermia treatment advances for brain tumors
GP Skandalakis, DR Rivera, CD Rizea… - International Journal …, 2020 - Taylor & Francis
Hyperthermia therapy (HT) of cancer is a well-known treatment approach. With the advent of
new technologies, HT approaches are now important for the treatment of brain tumors. We …
new technologies, HT approaches are now important for the treatment of brain tumors. We …
[HTML][HTML] A systematic review informing the management of symptomatic brain radiation necrosis after stereotactic radiosurgery and international stereotactic …
B Vellayappan, MJ Lim-Fat, R Kotecha… - International Journal of …, 2024 - Elsevier
Background Radiation necrosis (RN) secondary to stereotactic radiosurgery is a significant
cause of morbidity. The optimal management of corticosteroid-refractory brain RN remains …
cause of morbidity. The optimal management of corticosteroid-refractory brain RN remains …
Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent IDH wild-type glioblastoma
Background Treatment options for unresectable new and recurrent glioblastoma remain
limited. Laser ablation has demonstrated safety as a surgical approach to treating primary …
limited. Laser ablation has demonstrated safety as a surgical approach to treating primary …
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma
E Hasanov, DN Yeboa, MD Tucker… - CA: A Cancer …, 2022 - Wiley Online Library
Brain metastases are a challenging manifestation of renal cell carcinoma. We have a limited
understanding of brain metastasis tumor and immune biology, drivers of resistance to …
understanding of brain metastasis tumor and immune biology, drivers of resistance to …
Ablative brain surgery: an overview
A Franzini, S Moosa, D Servello, I Small… - International Journal …, 2019 - Taylor & Francis
Background: Ablative therapies have been used for the treatment of neurological disorders
for many years. They have been used both for creating therapeutic lesions within …
for many years. They have been used both for creating therapeutic lesions within …
Surgical management of brain metastasis: challenges and nuances
CI Ene, SD Ferguson - Frontiers in oncology, 2022 - frontiersin.org
Brain metastasis is the most common type of intracranial tumor. The contemporary
management of brain metastasis is a challenging issue and traditionally has carried a poor …
management of brain metastasis is a challenging issue and traditionally has carried a poor …
Laser ablation of abnormal neurological tissue using robotic neuroblate system (LAANTERN): 12-month outcomes and quality of life after brain tumor ablation
BACKGROUND Laser Ablation of Abnormal Neurological Tissue using Robotic NeuroBlate
System (LAANTERN) is an ongoing multicenter prospective NeuroBlate (Monteris Medical) …
System (LAANTERN) is an ongoing multicenter prospective NeuroBlate (Monteris Medical) …